Analytics: A Referee for the Tug-of-War Between MSC-EVs’ Nature & Nurture December 20, 2024 Bioprocessing, Exosomes / Extracellular Vesicles
Cytiva & RoosterBio’s Collaboration Yields Breakthroughs to Make Exosome Manufacture Easier from… October 29, 2024 Biomanufacturing, Exosomes / Extracellular Vesicles
Leaving Flatland Behind – A View from Experience in 3D Adherent Cell Culture for Advanced Therapies June 18, 2024 Biomanufacturing, Bioprocessing
Final Product Containers for Cell Therapies August 21, 2020 Biomanufacturing, Bioprocessing, Cell Therapy
MSCs as Medical Stockpiled Countermeasures: Cellular “First Responders” for COVID-19 and… May 20, 2020 Biomanufacturing, Cell Therapy, COVID-19
Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19 March 13, 2020 Biomanufacturing, Cell Therapy, Corporate, COVID-19
Good Manufacturing Practice for Cell & Cell-Based Therapies: Facilities & Quality Control June 29, 2017 Quality & Regulatory
